Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study

Abstract Background Previous studies have confirmed that systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) can predict the prognosis and chemotherapy efficacy of various malignant tumors. However, to the best of our knowledge, no study investigated the SII combined with...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ping’an Ding, Honghai Guo, Chenyu Sun, Peigang Yang, Na Hyun Kim, Yuan Tian, Yang Liu, Pengpeng Liu, Yong Li, Qun Zhao
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2022-03-01
Saila:	BMC Gastroenterology
Gaiak:	Systemic immune-inflammatory index (SII) Prognostic nutritional index (PNI) Chemosensitivity Immunotherapy Locally advanced gastric cancer
Sarrera elektronikoa:	https://doi.org/10.1186/s12876-022-02199-9
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!